These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9823969)
1. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN. Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969 [TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Rhei E; Kang L; Bogomolniy F; Federici MG; Borgen PI; Boyd J Cancer Res; 1997 Sep; 57(17):3657-9. PubMed ID: 9288766 [TBL] [Abstract][Full Text] [Related]
3. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392 [TBL] [Abstract][Full Text] [Related]
4. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Steck PA; Pershouse MA; Jasser SA; Yung WK; Lin H; Ligon AH; Langford LA; Baumgard ML; Hattier T; Davis T; Frye C; Hu R; Swedlund B; Teng DH; Tavtigian SV Nat Genet; 1997 Apr; 15(4):356-62. PubMed ID: 9090379 [TBL] [Abstract][Full Text] [Related]
5. PTEN/MMAC1 expression in melanoma resection specimens. Deichmann M; Thome M; Benner A; Egner U; Hartschuh W; Näher H Br J Cancer; 2002 Dec; 87(12):1431-6. PubMed ID: 12454773 [TBL] [Abstract][Full Text] [Related]
6. Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Reifenberger J; Wolter M; Boström J; Büschges R; Schulte KW; Megahed M; Ruzicka T; Reifenberger G Virchows Arch; 2000 May; 436(5):487-93. PubMed ID: 10881743 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. Whang YE; Wu X; Suzuki H; Reiter RE; Tran C; Vessella RL; Said JW; Isaacs WB; Sawyers CL Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5246-50. PubMed ID: 9560261 [TBL] [Abstract][Full Text] [Related]
8. PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408 [TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in advanced gastric carcinomas. Wang JY; Huang TJ; Chen FM; Hsieh MC; Lin SR; Hou MF; Hsieh JS Virchows Arch; 2003 May; 442(5):437-43. PubMed ID: 12695913 [TBL] [Abstract][Full Text] [Related]
10. Analysis of PTEN and the 10q23 region in primary prostate carcinomas. Feilotter HE; Nagai MA; Boag AH; Eng C; Mulligan LM Oncogene; 1998 Apr; 16(13):1743-8. PubMed ID: 9582022 [TBL] [Abstract][Full Text] [Related]
11. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas. Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865 [TBL] [Abstract][Full Text] [Related]
12. Identification of PTEN mutations in metastatic melanoma specimens. Celebi JT; Shendrik I; Silvers DN; Peacocke M J Med Genet; 2000 Sep; 37(9):653-7. PubMed ID: 10978354 [TBL] [Abstract][Full Text] [Related]
13. Expression of PTEN in malignant and non-malignant human prostate tissues: comparison with p27 protein expression. Fenic I; Franke F; Failing K; Steger K; Woenckhaus J J Pathol; 2004 May; 203(1):559-66. PubMed ID: 15095479 [TBL] [Abstract][Full Text] [Related]
14. Somatic mutation of PTEN in bladder carcinoma. Aveyard JS; Skilleter A; Habuchi T; Knowles MA Br J Cancer; 1999 May; 80(5-6):904-8. PubMed ID: 10360673 [TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical mapping of the phosphatase and tensin homolog (PTEN/MMAC1) tumor suppressor protein in human gliomas. Fults D; Pedone C Neuro Oncol; 2000 Apr; 2(2):71-9. PubMed ID: 11303623 [TBL] [Abstract][Full Text] [Related]
16. The expression profile for the tumour suppressor gene PTEN and associated polymorphic markers. Hamilton JA; Stewart LM; Ajayi L; Gray IC; Gray NE; Roberts KG; Watson GJ; Kaisary AV; Snary D Br J Cancer; 2000 May; 82(10):1671-6. PubMed ID: 10817502 [TBL] [Abstract][Full Text] [Related]
17. Mutations of PTEN/MMAC1 in primary prostate cancers from Chinese patients. Dong JT; Li CL; Sipe TW; Frierson HF Clin Cancer Res; 2001 Feb; 7(2):304-8. PubMed ID: 11234884 [TBL] [Abstract][Full Text] [Related]
18. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738 [TBL] [Abstract][Full Text] [Related]
19. A heterozygous frameshift mutation of the PTEN/MMAC1 gene in a patient with Lhermitte-Duclos disease - only the mutated allele was expressed in the cerebellar tumor. Iida S; Tanaka Y; Fujii H; Hayashi S; Kimura M; Nagareda T; Moriwaki K Int J Mol Med; 1998 Jun; 1(6):925-9. PubMed ID: 9852626 [TBL] [Abstract][Full Text] [Related]